Daniel J. Maslyar
Daniel J. Maslyar publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Prostate Cancer Treatment and Research, PI3K/AKT/mTOR signaling in cancer and Cancer Treatment and Pharmacology.
- World rank
- #412,892 of 7,710,434 ranked researchers
- Rank in United States
- #146,071 of 1,627,098
- Works
- 78
- Citations
- 2.9k
- Citations per work
- 37.5
What does Daniel J. Maslyar research?
Daniel J. Maslyar's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3545.0%
- Medicine3545.0%
- Life Sciences2330.0%
- Everything else2025.0%
- 1Molecular Biology21% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Oncology19% of their works
- 4Reproductive Medicine5% of their works
- 5Immunology5% of their works
- 6Biotechnology4% of their works
Research topics
Which keywords describe Daniel J. Maslyar's research?
The keywords of their largest research topics: Clinical Trials, Biomarkers, Genomic Profiling, Immunotherapy, Chemotherapy, Metastatic Breast Cancer, Androgen Receptor and Breast Cancer.
- CDK4/6 Inhibitors
- Trastuzumab
- HER2
- Bacterial Therapy
- Ovarian Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Signaling
- Breast Cancer
- Metastatic Breast Cancer
- Immunotherapy
- Biomarkers
- Clinical Trials
- Genomic Profiling
- Chemotherapy
- Androgen Receptor
- Prostate Cancer
- mTOR
- Genomic Analysis
- Taxanes
- EGFR Mutations
- Targeted Therapy
- Tumor Targeting
- Palbociclib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Clinical Trials263 topics
- Biomarkers202 topics
- Genomic Profiling172 topics
- Immunotherapy172 topics
- Chemotherapy152 topics
- Metastatic Breast Cancer142 topics
- Androgen Receptor111 topic
- Breast Cancer112 topics
- Prostate Cancer111 topic
- Signaling101 topic
- mTOR101 topic
- Chemotherapy-Induced Peripheral Neuropathy91 topic
- Genomic Analysis91 topic
- Ovarian Cancer91 topic
- Taxanes91 topic
- Bacterial Therapy61 topic
- EGFR Mutations61 topic
- HER261 topic
- Targeted Therapy61 topic
- Trastuzumab61 topic
- Tumor Targeting61 topic
- CDK4/6 Inhibitors51 topic
- Palbociclib51 topic
Where does Daniel J. Maslyar work?
Daniel J. Maslyar's main affiliation in the publication record is Tennessee Oncology, United States.
How many publications and citations does Daniel J. Maslyar have?
OpenAlex counts 78 works and 2,928 citations for Daniel J. Maslyar, an h-index of 23, ranking #412,892 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel J. Maslyar. Posts are plain text and can be reported.